# Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex

> **NCT06089252** · PHASE2 · COMPLETED · sponsor: **Iveriapharma LLC** · enrollment: 30 (actual)

## Conditions studied

- HSV Infection

## Interventions

- **DRUG:** walnut extract

## Key facts

- **NCT ID:** NCT06089252
- **Lead sponsor:** Iveriapharma LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11-27
- **Primary completion:** 2007-12-28
- **Final completion:** 2008-01-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089252, "Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06089252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*